Note 9 – Inventories Audited

 

million CHF 2017 2016
     
Inventories 1,288 1,006
Value adjustments (111) (109)
Total 1,177 897


 

million CHF 2017 2016
     
Raw materials 25% 292 22% 200
Work in progress 6% 67 6% 58
Finished goods 50% 594 49% 439
Other 19% 224 22% 200
Total 100% 1,177 100% 897

 

By Operating Segments1

million CHF 2017 22016
     
Specialty Ingredients 45% 3459 48% 429
Pharma&Biotech 39% 3528 52% 468
Capsugel 16% 190 0% 0
Total 100% 1,177 100% 897

 

The development of inventory value adjustments in 2017 is shown as follows:

Inventory Write-Downs

million CHF 2017 2016
  Raw materials Work in progress and finished goods Other Total Total
           
At 1 January 13 59 37 109 100
Increase 6 278 11 295 273
Reversal / Utilization of write-downs (5) (279) (8) (292) (260)
Transfer to assets held for sale 0 (2) 0 (2) (8)
Currency translation differences 0 1 0 1 4
At 31 December 14 57 40 111 109


The cost of inventories recognized as expenses during the period and included in “Cost of goods sold” amounted to CHF 3,083 million (2016: CHF 2,633 million).